Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Amarantus Bioscience Holdi AMBS
Posted On: 06/15/2014 12:22:29 PM
Post# of 30066
Posted By: WCoastGuynCA
"Technology Helps Recruit and Enroll the Right Patients for Clinical Trials"

"This makes the effort of recruiting qualified patients, and retaining those enrolled patients through the end of a study, the greatest barriers to clinical trial completion and time to a full data set for analysis and evaluation. Nearly eighty percent of clinical trials in the U.S. do not meet enrollment timelines and dropout rates are significant ."

http://patientpoint.com/blog/technology-helps...cal-trials

"Big pharma" will demand access to LymPro.

Stay tuned for news.

Twitter: @AmarantusBio .... 10,000 followers.













(0)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site